Volume 8, Number 10—October 2002
THEME ISSUE
Bioterrorism-related Anthrax
Bioterrorism-related Anthrax
Coordinated Response to Reports of Possible Anthrax Contamination, Idaho, 2001
Leslie Tengelsen*
, Richard Hudson*, Shana Barnes†, and Christine G. Hahn*
, Richard Hudson*, Shana Barnes†, and Christine G. Hahn*
Table
Clinical comparison of confirmed versus suspected inhalational anthrax cases
| Characteristics | aConfirmed cases, n=10 (%) | Idaho suspected cases, n=9b (%) |
|---|---|---|
| Postal worker or mail sorter | 8 (80) | 6/11c (54) |
| Fever/chills | 10 (100) | 2 (22) |
| Fatigue/malaise | 10 (100) | 8 (89) |
| Sweats | 7 (70) | 2 (22) |
| Cough | 9 (90) | 7 (78) |
| Nausea or vomiting | 9 (90) | 2 (22) |
| Dyspnea | 8 (80) | 3 (33) |
| Rhinorrhea | 1 (10) | 4 (44) |
aCases confirmed by Centers for Disease Control and Prevention.
bNine of the suspected inhalational cases had charts available for review.
cEleven suspected inhalational anthrax cases and one suspected cutaneous case.
Page created: July 19, 2010
Page updated: July 19, 2010
Page reviewed: July 19, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.